Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Liuchow, China (545026) as a recruitment site and removed Liuzhou, China (545026). The page revision was updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-28T01:25:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all be about the study, and updated the page revision to v3.3.1. Removed the older PubMed-listed publication description and the previous revision reference (v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-21T01:06:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Taiwan site entry changed from 'Tainan City' to 'Tainan' with the same postal code 70403; removal of a government funding status notice from the page.
    Difference
    0.2%
    Check dated 2025-11-13T22:01:32.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page; the content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T12:10:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Adds more recent date references (10/9/2025, 10/10/2025, and 2025-10) and removes earlier September 2025 references (2025-09-15, 2025-09-11, and 2025-09).
    Difference
    0.2%
    Check dated 2025-10-16T06:27:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding notice and operating status for NIH Clinical Center, plus a version upgrade to v3.2.0. Deletion of v3.0.2 indicates the previous version is obsolete.
    Difference
    2%
    Check dated 2025-10-01T14:19:47.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.